Monoval-LdC: efficient prodrug of 2'-deoxy-beta-L-cytidine (L-dC), a potent and selective anti-HBV agent. 2003

S Benzaria, and C Pierra, and D Bardiot, and E Cretton-Scott, and E G Bridges, and X J Zhou, and D Standring, and G Gosselin
Laboratoire Coopératif Idenix-CNRS-Université Montpellier II, CC 008, Montpellier, France.

In order to improve the oral bioavailability of LdC, valinyl esters were prepared as prodrugs. We report here the syntheses of the 3'-mono-, 5'-mono, and 3',5'-di-O-valinyl esters of LdC. The comparison of their ease of synthesis, their physicochemical properties, as well as their pharmacokinetic parameters in cynomologus monkeys has revealed 3'-mono-O-valinyl derivative as the most promising of the studied prodrugs. This compound is being developed as a new anti-HBV agent.

UI MeSH Term Description Entries
D008252 Macaca fascicularis A species of the genus MACACA which typically lives near the coast in tidal creeks and mangrove swamps primarily on the islands of the Malay peninsula. Burmese Long-Tailed Macaque,Crab-Eating Monkey,Cynomolgus Monkey,M. f. aurea,M. fascicularis,Macaca fascicularis aurea,Monkey, Crab-Eating,Monkey, Cynomolgus,Crab-Eating Macaque,Burmese Long Tailed Macaque,Crab Eating Macaque,Crab Eating Monkey,Crab-Eating Macaques,Crab-Eating Monkeys,Cynomolgus Monkeys,Long-Tailed Macaque, Burmese,Macaque, Burmese Long-Tailed,Macaque, Crab-Eating,Monkey, Crab Eating
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D003841 Deoxycytidine A nucleoside component of DNA composed of CYTOSINE and DEOXYRIBOSE. Cytosine Deoxyribonucleoside,Cytosine Deoxyriboside,Deoxyribonucleoside, Cytosine,Deoxyriboside, Cytosine
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

S Benzaria, and C Pierra, and D Bardiot, and E Cretton-Scott, and E G Bridges, and X J Zhou, and D Standring, and G Gosselin
January 1998, Bioorganic & medicinal chemistry letters,
S Benzaria, and C Pierra, and D Bardiot, and E Cretton-Scott, and E G Bridges, and X J Zhou, and D Standring, and G Gosselin
August 2015, European journal of medicinal chemistry,
S Benzaria, and C Pierra, and D Bardiot, and E Cretton-Scott, and E G Bridges, and X J Zhou, and D Standring, and G Gosselin
January 2001, Nucleosides, nucleotides & nucleic acids,
S Benzaria, and C Pierra, and D Bardiot, and E Cretton-Scott, and E G Bridges, and X J Zhou, and D Standring, and G Gosselin
December 2000, The Journal of organic chemistry,
S Benzaria, and C Pierra, and D Bardiot, and E Cretton-Scott, and E G Bridges, and X J Zhou, and D Standring, and G Gosselin
June 1979, Proceedings of the National Academy of Sciences of the United States of America,
S Benzaria, and C Pierra, and D Bardiot, and E Cretton-Scott, and E G Bridges, and X J Zhou, and D Standring, and G Gosselin
December 2001, Organic letters,
S Benzaria, and C Pierra, and D Bardiot, and E Cretton-Scott, and E G Bridges, and X J Zhou, and D Standring, and G Gosselin
May 1980, Antimicrobial agents and chemotherapy,
S Benzaria, and C Pierra, and D Bardiot, and E Cretton-Scott, and E G Bridges, and X J Zhou, and D Standring, and G Gosselin
May 2018, Medicinal research reviews,
S Benzaria, and C Pierra, and D Bardiot, and E Cretton-Scott, and E G Bridges, and X J Zhou, and D Standring, and G Gosselin
March 2002, Carbohydrate research,
Copied contents to your clipboard!